ProPhase Labs Q2 FY26 net loss narrows to $3 million; revenue falls to $1 millionPUBT·4 hours agoPRPH-6.13%
ProPhase Labs delays Q2 Form 10-Q filing as auditor review takes longerPUBT·Aug 14 at 03:35 PMPRPH-6.13%
ProPhase Labs enters senior secured convertible loan agreement with J.J. Astor & Co for $2.09 million principal amountPUBT·Aug 6 at 05:05 PMPRPH-6.13%
Niche US Assets Catch Fire: Inside the Latest Moves from Sezzle to Sol StrategiesGlobal Report·Jul 22 at 04:17 AMPRPH-6.13%SEZL+1.53%
ProPhase Labs, Inc. 1Q 2026: Revenue $478K, EPS $(0.43) — 10-Q SummaryTradingView·Jun 30 at 04:01 PMPRPH-6.13%
PRPH: Net loss widened to $5.4 million amid revenue decline and ongoing liquidity challengesQuartr·Jun 30 at 03:53 PMPRPH-6.13%
ProPhase Labs Q1 FY26 operating loss widens to $5.4 million; revenue drops 64.29% to $0.5 millionPUBT·Jun 30 at 03:51 PMPRPH-6.13%
ProPhase Labs, Inc. FY 2025: Revenue $4.35M, EPS ($1.74) — 10-K SummaryTradingView·Jun 1 at 04:15 PMPRPH-6.13%
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform | PRPH Stock NewsStockTitan·Apr 15 at 12:05 AMPRPH-6.13%IBB+6.58%
Medipharm Labs Earnings Call Highlights Global Growth PivotTip Ranks·Apr 4 at 07:21 PMIXJ+3.32%LABU+17.78%
ProPhase Labs Explores Strategic Options for BE-Smart TestTip Ranks·Feb 13 at 04:53 PMPBE+3.13%PRPH-6.13%
ProPhase Labs Issues Update on Crown Medical CollectionsTip Ranks·Jan 27 at 10:27 AMIDNA+13.26%IHF+0.04%
